PPT-OHSU Updates in Hematology

Author : calandra-battersby | Published Date : 2016-03-09

and Breast Cancer Conference CML ASH Update Michael J Mauro MD CML Abstracts Novel Agents Abstract 109 A Pivotal Phase 2 Study of Ponatinib in Patients with

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "OHSU Updates in Hematology" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

OHSU Updates in Hematology: Transcript

and Breast Cancer Conference CML ASH Update Michael J Mauro MD CML Abstracts Novel Agents Abstract 109 A Pivotal Phase 2 Study of Ponatinib in Patients with CML and Ph ALL Resistant or Intolerant to Dasatinib or Nilotinib or with the T315I Mutation. Donald Girard, M.D.. Sydney . Ey. , Ph. D.. Mark . Kinzie. , M.D., Ph.D.. Mary . Moffit. , Ph.D., R.N.. Our mission is to enhance the well-being of faculty with coaching and counseling services.. OHSU . Presented by: . the folks in RDA. with today’s emcee. , Darlene Kitterman. Date: . November 20, 2014. Research Administration Information Network. RAIN Agenda. Introduction. Updates & timely information:. Targeted Cancer Therapies. Dr . Ongóndi. .M. KNH-Dept. Internal Medicine. Hemato. -Oncology. Objectives. Traditional chemotherapy. Targeted chemotherapy. Country status. Challenge !!!. Administer sufficiently high dose of . Dolores Zegar Judkins, MLS. Head, Instruction, Research & Outreach. OHSU Library. judkinsd@ohsu.edu. Ways to get help:. Ask a librarian. Chat. Email. Phone. You need one. Where you can get one. Library circulation desk. J. Christian Barrett, MD. Pathophysiology of PNH. Paroxysmal Nocturnal . Hemoglobinura. A disease of the hematopoietic stem cell. Non-malignant . clonal. disease. Defective post-translational processing of . Susan . Claster. MD. Division of Hematology Oncology. UCI Medical Center. Thank you. What is Benign Hematology?. Clotting/thrombophilia. Bleeding disorders. Hemoglobinopathies. Non malignant disorders of . Outline. Anemia. Thrombocytopenia. Neutropenia. Coagulation disorders. Lymphoma. Terese. Winslow, Lydia . Kibiuk. , http://. stemcells.nih.gov. /info/. scireport. /pages/chapter5.aspx. Terese. Winslow, Lydia . PGY-1. Timeline: . PGY-1. Timeline: . PGY-1. Timeline: . PGY-2. Timeline: . PGY-2. Timeline: . PGY-2. Timeline: . PGY-3. Timeline: . PGY-3. Timeline: . PGY-3. The Fellowship-Scholarship Timeline. Aug Oct Dec Feb Apr. The NIST standards establish PurposeThe purpose of this memorandum is to provide OHSU users with guidance for responding toinquiries regarding OHSU146s compliance with FISMA OHSU is not a federal agen Specializing in the diagnosis and management of hematological disorders the Hematology practice at Valley Children146s provides consultations 24 hours a day We provide care for a large pediatric patie Dr. . Versha. Prasad. Anticoagulants Used In the Hematology Laboratory. Anticoagulants are defined as substances which prevent blood clotting / coagulation, and allow separation of the blood into cellular and liquid (plasma) components. Generally plasma contains coagulation factors. . , RN. Evy Warmbier, MSN, RN, CNE. Objectives. To Identify the Basic Hematological Components. To Understand the Clotting Cascade. To Relate the Fibrinolytic Systems Regarding Medication Administration. Alice J. Cohen, M.D., F.A.C.P.. Newark Beth Israel Medical Center. Associate Clinical Professor of Medicine. Rutgers - New Jersey Medical School. Newark, NJ. Disclosures. None. Scope of the Problem. Welcome to the Oncology Clinic In the following pages, we will help you with: hat to expect at your first visit ow to get to the Hematology/Oncology Clinicow to make the most of your appointmentWe

Download Document

Here is the link to download the presentation.
"OHSU Updates in Hematology"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.